
222 E 41st StreetNew York, NY 10017
Fax+1 212-263-7721
Overview of Dr. Andrews
Dr. Jinsy Andrews, based in New York, NY, is a neurologist with subspecialties in neuromuscular medicine and neurophysiology. She trained at the University of Connecticut and Columbia Universtiy, also earning an MSc in Biostatistics from Columbia University. Dr. Andrews is the Director of the ALS Center and Director of Clinical Trials at NYU Langone Medical Center and is a part-time Staff Physician at James J. Peters Veterans Affairs Medical Center. Her expertise includes amyotrophic lateral sclerosis (ALS), electromyography, and muscular dystrophy, with several publications on ALS. She has conducted clinical trials investigating treatments for ALS and has received honors such as a Fellowship from the American Academy of Neurology, Fellowship from the American Neurologcal Associate, and the Diamond Award for ALS Research.
Education & Training
Columbia University Mailman School of Public HealthMSc, Biostatistics, 2007 - 2009
New York Presbyterian Hospital (Cornell Campus)Fellowship, Clinical Neurophysiology, 2006 - 2007
New York Presbyterian Hospital (Columbia Campus)Fellowship, Neuromuscular Medicine (Neurology), 2005 - 2006
University of ConnecticutResidency, Neurology, 2002 - 2005
University of ConnecticutInternship, Internal Medicine, 2001 - 2002
Certifications & Licensure
NJ State Medical License 2021 - 2027
CA State Medical License 2016 - 2026
NY State Medical License 2005 - 2026
CT State Medical License 2010 - 2017
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine
Awards, Honors, & Recognition
- Fellow American Neurological Association, 2022
- Fellow of the American Academy of Neurology American Academy of Neurology (AAN), 2018
- Diamond Award for ALS Research Wings Over Wall Street/MDA, 2009
Clinical Trials
- Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2009 Jan 01
- Ciprofloxacin/Celecoxib Combination in Patients With ALS Start of enrollment: 2019 Dec 09
Publications & Presentations
PubMed
- Startle Reflex in Primary Lateral Sclerosis (PLS): A Comparison With Amyotrophic Lateral Sclerosis (ALS).Grace E Jang, Ikjae Lee, Jinsy A Andrews, Ying Kuen Ken Cheung, Mersad Redzepagic
Muscle & Nerve. 2026-02-01 - Long-Term Tofersen in SOD1 Amyotrophic Lateral Sclerosis.Timothy M Miller, Merit E Cudkowicz, Pamela J Shaw, Angela Genge, Gen Sobue
JAMA Neurology. 2026-02-01 - Quantitative Measures of Time to Loss of 15% Vital Capacity and Survival Extension in Slowly Progressive Amyotrophic Lateral Sclerosis (ALS) Patients Treated with the ...Namita A Goyal, Jinsy A Andrews, Björn E Oskarsson, Martina H Wiedau, Edward J Kasarskis
Biomedicines. 2025-12-12
Press Mentions
Renowned Neuromuscular Expert Will Head New NYU Langone ALS CenterNovember 19th, 2025
ProJenX Announces Formation of Clinical Advisory BoardAugust 27th, 2024
New Drugs for ALS and Alzheimer’s Show Great PromiseSeptember 30th, 2022
Grant Support
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2027
- Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2027
- Access for All in ALS (ALL ALS) East Clinical Coordinating CenterMASSACHUSETTS GENERAL HOSPITAL2023–2027
- Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).NEW YORK UNIVERSITY SCHOOL OF MEDICINE2023–2027
Professional Memberships
- Fellow
- Member
- American Neurological Association - ANAFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









